Bochum researchers (IMAGE)
Caption
Ilya Ayzenberg (left) and Thomas Grüter want to draw the attention of doctors to the possibility of anti-IgLON disease.
Credit
RUB, Marquard
Usage Restrictions
The images are free to use for members of the press, provided the relevant copyright notice is included. The images may be used solely for press coverage of Ruhr University Bochum that relates to the contents of the press release “Start Immunotherapy for Anti-IgLON5 Disease as Early as Possible”.
License
Original content